Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 52, Issue 7, 2009, Pages 814-818

  Lowas, Stefanie R ^a,b,c   Marks, Daniel ^a   Malempati, Suman ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^c 397 PRB   (United States)

Author keywords

ALL; Hematology oncology; Pediatric endocrinology

Indexed keywords

ASPARAGINASE; ASPARAGINASE MACROGOL; DEXAMETHASONE; GLUCOSE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CANCER CHEMOTHERAPY; CHI SQUARE TEST; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OBESITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; TRANSIENT HYPERGLYCEMIA; TREATMENT RESPONSE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEXAMETHASONE; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; POLYETHYLENE GLYCOLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; PREVALENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 67650435068     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21980     Document Type: Article

References (25)

1. Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 2002;16:225-243. (Pubitemid 35230786)
2. Cetin M, Yetgin S, Kara A, et al. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. J Med 1994;25:219-229. (Pubitemid 24282287)
3. Pui CH, Burghen GA, Bowman WP, et al. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr 1981;99:46-50. (Pubitemid 11046416)
4. Baillargeon J, Langevin AM, Mullins J, et al. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2005;45:960-963. (Pubitemid 41552166)
5. Belgaumi AF, Al-Bakrah M, Al-Mahr M, et al. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer 2003;97:2898-2903. (Pubitemid 36605160)
6. Dacou-Voutetakis C, Palis J, Haidas S, et al. Abnormal glucose tolerance in children with acute leukemia. Effect of induction chemotherapy including L-asparaginase. Am J Pediatr Hematol Oncol 1983;5:139-146.
7. Gillette PC, Hill LL, Starling KA, et al. Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia. J Pediatr 1972;81:109-111.
8. Jaffe N. Diabetes mellitus secondary to L-asparaginase therapy. J Pediatr 1972;81:1220-1221.
9. Ortega JA, Nesbit ME, Jr., Donaldson MH, et al. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res 1977;37:535-540. (Pubitemid 8030402)
10. Carpentieri U, Balch MT. Hyperglycemia associated with the therapeutic use of L-asparaginase: possible role of insulin receptors. J Pediatr 1978;93:775-778. (Pubitemid 8397584)
11. Roberson JR, Raju S, Shelso J, et al. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;50:1207-1212. (Pubitemid 351555545)
12. Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-1732.
13. Olefsky JM, Kimmerling G. Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci 1976;271:202-210.
14. Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996;15:135-157.
15. Clausen N, Nielsen JH. Direct long-term effects of L-asparaginase on rat and human pancreatic islets. Pediatr Res 1989;26:158-161. (Pubitemid 19195105)
16. Kahn A, Adachi M, Hill JM. Potentiation of diabetogenic effect of L-asparaginase by prednisolone. Horm Metab Res 1970;2:275-276.
17. Weiser MA, Cabanillas ME, Konopleva M, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer 2004; 100:1179-1185. (Pubitemid 38325945)
18. Sonabend RY, McKay SV, Okcu MF, et al. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer 2008;51:387-392.
19. Kaufman FR. Type 2 diabetes in children and youth. Endocrinol Metab Clin North Am 2005;34:659-676, ix-x.
20. Molnar D. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord 2004;28:S70-S74. (Pubitemid 39564321)
21. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 2003;101:3809-3817. (Pubitemid 36857851)
22. van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, et al. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006;46:88-93. (Pubitemid 41779323)
23. Van Dongen-Melman JE, Hokken-Koelega AC, Hahlen K, et al. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995;38:86-90.
24. Reilly JJ, BroughamM,MontgomeryC, et al. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 2001;86:3742-3745. (Pubitemid 32755970)
25. Avramis VI, Sencer S, Periclou AP, et al.Arandomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children's Cancer Group study. Blood 2002;99:1986-1994. (Pubitemid 34525479)